Purchase Order HHSN272201200407P
Award Date 4/20/12
Potential Completion Date 5/19/12
Potential Value $16K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20892, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Otogenetics Corporation, a minority-owned, small disadvantaged business, has been awarded a $24,849 firm-fixed-price purchase order contract by the National Institutes of Health's National Institute of Arthritis and Musculoskeletal and Skin Diseases. The contract, which is not set aside for any specific business category, is for the provision of next-generation sequencing laboratory services, including whole exome sequencing, clinical genetic testing, and data analysis, to support research...
- The U.S. government awarded a $24,997 purchase order to Otogenetics Corporation for RNA sequencing (RNA SEQ) services. This firm fixed-price contract was executed on April 26, 2016, with a completion date of May 6, 2016, and was performed at the company's facility in Dunwoody, Georgia. The contract was funded by a civilian federal agency within the Southeast Area and was not designated as a set-aside for any specific business category. Otogenetics Corporation is a next-generation sequencing...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm fixed-price purchase order to Novogene Corp Inc., a minority-owned small business, for RNA sequencing services. The $13,410.00 contract has a completion date of June 30, 2024. Novogene is a provider of next-generation sequencing technologies and has delivered sequencing and bioinformatics services to support biomedical research across various federal...
- The Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute awarded a $24,577.00 firm fixed-price purchase order to Novogene Corp Inc., a minority-owned small business, for DNA and RNA sequencing services. This contract is set aside for small businesses. Novogene is a provider of next-generation sequencing technologies that has delivered services to support various federal agencies' biomedical, agricultural, environmental, and basic...
- This federal contract award is for $143,850.00 to Novogene Corp Inc., a minority-owned small business, by the Department of Health and Human Services' National Institutes of Health National Institute on Drug Abuse. The contract is a firm fixed price purchase order for genomic sequencing and bioinformatics services to support biomedical research. Novogene has previously received over 100 prime contracts from federal agencies including the NIH, Department of Veterans Affairs, Department of...
- This is a firm fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) Office of Acquisition Services to Otogenetics Corporation, a minority-owned, small disadvantaged business, for laboratory supplies and other functions. The contract has a ceiling value of $80,000.00 and a period of performance that ends on April 1, 2016. Otogenetics Corporation is a next-generation sequencing laboratory service provider that specializes in services such as whole exome...
- This is a firm fixed-price purchase order awarded by the National Institute of Child Health and Human Development (NICHD), a civilian agency within the U.S. Department of Health and Human Services. The $11,766 contract is for sequencing and analysis services to be provided by Novogene Corp Inc., a minority-owned small business. The services include next-generation sequencing of DNA and RNA samples, library preparation, and associated bioinformatics analysis. This contract is not designated as...
- Novogene Corp Inc., a minority-owned small business, has been awarded a firm fixed price purchase order contract valued at $24,350 by the Department of Health and Human Services' National Institutes of Health National Cancer Institute. The contract is for laboratory testing services to support genomic sequencing and bioinformatics research efforts. Specifically, Novogene will provide DNA/RNA sample sequencing and data analysis services leveraging Illumina and PacBio platforms, including whole...
- This $20,850 firm fixed-price purchase order was awarded to Novogene Corp Inc., a minority-owned small business, by the National Institute of Allergy and Infectious Diseases (NIAID) on September 12, 2024. The contract is for RNA sequencing services to support NIAID's biomedical research efforts, with a completion date of September 11, 2025. Novogene is an experienced provider of genomic sequencing and bioinformatics services to various federal agencies, holding multiple prime contracts and...
- The U.S. National Institute of Allergy and Infectious Diseases (NIAID) awarded a firm fixed-price purchase order contract to Novogene Corp Inc., a minority-owned small business, for RNA sequencing analysis services. The $10,880 contract has a completion date of December 11, 2024 and was not set aside. Novogene is a provider of genomic sequencing and bioinformatics services, supporting various federal agencies' biomedical, agricultural, environmental, and basic research efforts. This award...